MRNS - Marinus Pharmaceuticals Q2 2023 Earnings Preview

August, 09 2023 12:05 PM Marinus Pharmaceuticals Inc.

2023-08-09 12:05:45 ET

Marinus Pharmaceuticals ( NASDAQ: MRNS ) is scheduled to announce Q2 earnings results on Thursday, August 10th, before market open.
The consensus EPS Estimate is -$0.71 and the consensus Revenue Estimate is $5.74M (+218.9% Y/Y).
Over the last 1 year, MRNS has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
Over the last 3 months, EPS estimates have seen 3 upward revisions and 1 downward. Revenue estimates have seen 1 upward revision and 8 downward.

For further details see:

Company Name:	Marinus Pharmaceuticals Inc.
Stock Symbol:	MRNS
Market:	NASDAQ
Website:	marinuspharma.com